725 filings
Page 7 of 37
PRRN14A
j5ie se4z
15 Mar 23
Revised preliminary proxy statement filed by non-management
5:54pm
DEFA14A
009vpwl d5g
15 Mar 23
Additional proxy soliciting materials
7:36am
DEFC14A
dfhloal y68y67
15 Mar 23
Proxy in contested solicitation
7:03am
4
wkqph49lk nq99bci60b
13 Mar 23
ZEVRA THERAPEUTICS / Matthew R Plooster ownership change
7:59am
4
5pq8xygw brbcb
13 Mar 23
ZEVRA THERAPEUTICS / Timothy J. Sangiovanni ownership change
7:57am
4
384xjjm6
13 Mar 23
ZEVRA THERAPEUTICS / R. LaDuane Clifton ownership change
7:56am
4
114g0
13 Mar 23
ZEVRA THERAPEUTICS / David S Tierney ownership change
7:54am
4
qysgnqzc0r0ljh56ixie
13 Mar 23
ZEVRA THERAPEUTICS / Richard W Pascoe ownership change
7:53am
8-K
6omlr8wn068qxgq0yg
13 Mar 23
Regulation FD Disclosure
6:25am
UPLOAD
pcd wxjuqsn
10 Mar 23
Letter from SEC
12:00am
S-8
4ij 6e0q140
7 Mar 23
Registration of securities for employees
5:29pm
S-8
0if exta8ackah
7 Mar 23
Registration of securities for employees
5:28pm
DEFA14A
1lcxe5k8
7 Mar 23
Additional proxy soliciting materials
4:42pm
8-K
lrjzfn3 leh3134lr2v
7 Mar 23
Zevra Therapeutics Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Corporate Updates
8:20am
PRER14A
zfohbaa7z30
6 Mar 23
Preliminary revised proxy
4:39pm
CORRESP
d94uoat frk6seui04
6 Mar 23
Correspondence with SEC
12:00am
DFAN14A
cnpveoa 3qdp
3 Mar 23
Additional proxy materials by non-management
5:11pm
PREN14A
yayea8ky3emsirn
3 Mar 23
Preliminary proxy statement filed by non-management
3:11pm